---
title: Zenarestat
slug: zenarestat
qid: 
snapshot: enwiki-001330642061
content_hash: 
license: CC BY-SA 4.0
source: https://en.wikipedia.org/w/index.php?oldid=1330642061
tags: [106462793, 23468805, 23603337, 23815562, 26220375, 28387434, 28697645, 50769796, 65000658, 67803782]
---

# Zenarestat

> [!note] Provenance
> Snapshot `enwiki-001330642061` · content root `…`
> Derived from <https://en.wikipedia.org/w/index.php?oldid=1330642061> · Licensed CC BY-SA 4.0

Zenarestat (FK-366; FR-74366) is an aldose reductase inhibitor. It was investigated as a treatment of diabetic neuropathy and cataract, but its development was terminated.

Zenarestat (FK-366; FR-74366) is an aldose reductase inhibitor. It was investigated as a treatment of diabetic neuropathy and cataract, but its development was terminated. ==References== M. Hashimoto et al., EP 218999; eidem, US 4734419 (1987, 1988 both to Fujisawa) Inhibition kinetics and effect on sorbitol accumulation: S. Ao et al., Metabolism 40, 77 (1991) Pharmacokinetics and metabolism in diabetic rats: Y. Tanaka et al., Drug Metab. Dispos. 21, 677 (1993) M. Kanamaru et al., J. Clin. Pharmacol. 33, 1122 (1993).
